PrEPX South Australia
Alfred Health’s highly successful PrEPX study for those at risk for HIV infection will be expanded into South Australia thanks to a new partnership with South Australian Health & Medical Research Institute (SAHMRI) and SA Health.
The PrEPX Study is also being conducted in Victoria and Tasmania:
What is PrEPX-SA?
PrEPX-SA will monitor how providing large-scale access to Pre-Exposure Prophylaxis (PrEP) medication impacts the rate of new infections across the state. There will be 500 places available in the study.
This study is funded by the Government of South Australia. The South Australian Health & Medical Research Institute (SAHMRI) will provide the leadership and coordination of the project.
PrEPX-SA opened on the 15th May 2017. To access the study please contact one of the clinics below to make an appointment.
How will the study work?
Contact your preferred clinic to access PrEPX-SA. When booking an appointment let them know you are wanting to enrol in PrEPX-SA so they ensure you have a long enough appointment.
The following clinics are able to enrol people in PrEPX-SA
- Clinic 275 - phone (08) 8222 5075. PrEPX-SA patients will not be charged
- O’Brien St General Practice - phone (08) 8231 4026. PrEPX-SA patients will be bulk billed
- SHine-SA Hyde St - phone (08) 7099 5320 or (08) 7099 5300. Bulk billing appointments available
- Riverside Family Medical Practice - Ph: (08) 8275 9100. Bulk Billing for initial appointment, follow up appointments have normal consult fee
Before you attend your clinic appointment please watch the PrEPX video which will explain a lot about PrEP. Also read the consent form as you will need to sign a copy at your clinic appointment.
What costs are involved?
A PBS co-payment for the study medication will be in place for PrEPX-SA study participants.
We plan that the medication will be able to be collected from The Centre Pharmacy located in Central Market Arcade.
Costs:
- Concession: $6.30
- Non-concession: $38.80
In the study this co-payment cost will cover three months’ supply.
Criteria for the study
All people, regardless of sexual orientation or gender are eligible for the study. PrEPX-SA will enroll people whose sexual or injecting drug use activities means there is a high risk of acquiring HIV infection. This level of risk is defined through discussions with doctors, nurses or peer workers.
To be eligible for the study you will need to:
- have a medicare card
- be over 18 years of age
- have no confounding health issues for the study
More detailed criteria is available on the consent form attached below.
Information about PrEP
HIV Pre-Exposure Prophylaxis (PrEP) is a once-a-day medication for HIV negative people, to reduce their risk of acquiring HIV. It is recommended that PrEP is taken every day to effectively reduce the risk.
